Neurocrine Biosciences, Inc.NBIXNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Revenue minus cost of goods sold
Latest
$2.32B
↑ 152% above average
Average (9y)
$921.13M
Historical baseline
Range
High:$2.32B
Low:$15.00M
CAGR
+69.8%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $2.32B | +25.7% |
| 2023 | $1.85B | +26.1% |
| 2022 | $1.47B | +30.9% |
| 2021 | $1.12B | +8.1% |
| 2020 | $1.04B | +32.7% |
| 2019 | $780.70M | +74.9% |
| 2018 | $446.30M | +178.3% |
| 2017 | $160.37M | +969.1% |
| 2016 | $15.00M | -24.1% |
| 2015 | $19.77M | - |